Ckt2 Activators
Csnka2ip, encoding the casein kinase 2, alpha prime interacting protein, is primarily located in the nucleus, suggesting its involvement in nuclear signaling and regulatory processes. As an ortholog to human CSNKA2IP, the protein is evolutionarily conserved, emphasizing its functional significance across species. The predicted functions of Csnka2ip include interactions with casein kinase 2 subunit alpha' (CSNKA2), implying a role in modulating the activity of casein kinase 2, a key regulator in various cellular processes. Activation of Csnka2ip is influenced by a diverse set of chemical regulators that directly or indirectly impact its functions. Sodium butyrate and trichostatin A, as HDAC inhibitors, modulate histone acetylation, positively affecting Csnka2ip expression. Phorbol 12-myristate 13-acetate (PMA) and EGF directly activate Csnka2ip through PKC and EGFR signaling, respectively, while lithium chloride directly inhibits GSK-3β, leading to enhanced Csnka2ip activity. N-Acetylcysteine (NAC) modulates redox signaling, influencing Csnka2ip function directly, and wortmannin indirectly upregulates Csnka2ip by inhibiting PI3K-dependent pathways. Retinoic acid activates Csnka2ip through retinoic acid receptors, and forskolin modulates cAMP-dependent signaling, both affecting cellular processes associated with Csnka2ip. Valproic acid, as another HDAC inhibitor, and rapamycin, as an mTOR inhibitor, influence Csnka2ip expression and function, providing additional layers of regulation.
In summary, Csnka2ip emerges as a versatile player in cellular signaling and regulatory networks, with its activation intricately tied to diverse cellular processes influenced by a range of chemical regulators. The identified activators modulate epigenetic regulation, kinase signaling, and redox pathways, collectively influencing the functions associated with Csnka2ip. This dynamic regulation highlights the adaptability of Csnka2ip in responding to various environmental cues, underscoring its potential impact on cellular processes governed by casein kinase 2. The interplay between these activators provides insights into the nuanced regulatory mechanisms governing Csnka2ip and its role in cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Indirect activator of Csnka2ip through HDAC inhibition. Sodium butyrate inhibits HDACs, influencing histone acetylation and promoting Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating epigenetic regulation and affecting gene expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Csnka2ip through PKC signaling. PMA activates PKC, leading to increased Csnka2ip expression. This compound directly promotes Csnka2ip function by modulating PKC-dependent pathways and influencing cellular processes associated with Csnka2ip. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Direct activator of Csnka2ip via GSK-3β inhibition. Lithium chloride inhibits GSK-3β, positively influencing Csnka2ip function. This compound directly enhances Csnka2ip activity by modulating GSK-3β-dependent pathways and affecting cellular processes associated with Csnka2ip. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Upregulates Csnka2ip through retinoic acid receptors. Retinoic acid binds to receptors, influencing Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating retinoic acid receptor-dependent pathways and affecting gene expression associated with Csnka2ip. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Upregulates Csnka2ip through HDAC inhibition. Trichostatin A inhibits HDACs, influencing histone acetylation and promoting Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating epigenetic regulation and affecting gene expression associated with Csnka2ip. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Direct activator of Csnka2ip via modulation of redox signaling. NAC influences redox pathways, positively affecting Csnka2ip function. This compound directly enhances Csnka2ip activity by modulating redox-dependent pathways and affecting cellular processes associated with Csnka2ip. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Upregulates Csnka2ip through PI3K inhibition. Wortmannin inhibits PI3K, leading to increased Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating PI3K-dependent pathways and affecting gene expression associated with Csnka2ip. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Indirect activator of Csnka2ip through HDAC inhibition. Valproic acid inhibits HDACs, influencing histone acetylation and promoting Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating epigenetic regulation and affecting gene expression associated with Csnka2ip. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Upregulates Csnka2ip through mTOR inhibition. Rapamycin inhibits mTOR, influencing Csnka2ip expression. This compound indirectly activates Csnka2ip by modulating mTOR-dependent pathways and affecting gene expression associated with Csnka2ip. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Direct activator of Csnka2ip through histone modification. Butyric acid influences histone acetylation, positively affecting Csnka2ip function. This compound directly enhances Csnka2ip activity by modulating epigenetic regulation and affecting cellular processes associated with Csnka2ip. | ||||||